Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002412992 | SCV002712095 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-06-01 | criteria provided, single submitter | clinical testing | The c.185_186delGC pathogenic mutation, located in coding exon 1 of the MSH6 gene, results from a deletion of two nucleotides at nucleotide positions 185 to 186, causing a translational frameshift with a predicted alternate stop codon (p.R62Lfs*27). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV003465743 | SCV004196385 | likely pathogenic | Endometrial carcinoma | 2020-10-07 | criteria provided, single submitter | clinical testing |